Transfer factor immunotherapy as an adjunct to surgery in lung cancer
Fujisawa, T.
Nihon Kyobu Shikkan Gakkai Zasshi 23(1): 68-73
1985
ISSN/ISBN: 0301-1542 PMID: 3892117 Document Number: 253417
Document emailed within 1 workday
Related Documents
Burger, D.R.; Vetto, R.M.; Vandenbark, A.A. 1974: Transfer factor immunotherapy in human cancer Surgical Forum 25: 93-95Yang, S.C.; Owen-Schaub, L.; Mendiguren-Rodriguez, A.; Grimm, E.A.; Hong, W.K.; Roth, J.A. 1990: Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha Journal of Thoracic and Cardiovascular Surgery 99(1): 8
Fujisawa, T.; Yamaguchi, Y. 1983: Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types Gan no Rinsho. Japan Journal of Cancer Clinics 29(12): 1409-1416
Zduńczyk, A. 1980: Transfer factor (its use in immunotherapy of neoplasms and other diseases) Wiadomosci Lekarskie 33(11): 877-881
Miyazawa, N.; Tsuchiya, R.; Naruke, T.; Yoneyama, T.; Suemasu, K. 1985: BCG immunotherapy as an adjuvant to surgery in lung cancer. An analysis of lymphocyte subsets of the peripheral blood using monoclonal antibodies Nihon Kyobu Shikkan Gakkai Zasshi 23(1): 56-61
Iizasa, T.; Fujisawa, T. 2001: Surgery for non-small cell lung cancer based on the T factor Nihon Geka Gakkai Zasshi 102(7): 507-510
Xu, W.M. 1992: Determination of antigen-dependent activity of human lung cancer transfer factor by H3-leucine leucine leukocyte adherence inhibition assay Zhonghua Zhong Liu Za Zhi 14(2): 116-118
Grinevich, I.A.; Fil'chakov, F.V.; Shumilina, E.C.; Lën, A.D.; Shved, V.V. 2009: Transfer factor specific to mouse lung carcinoma of Lewis Voprosy Onkologii 55(5): 612-618
Słowik-Gabryelska, A.; Krzyśko, R. 1980: Transfer factor (TFX) dosage and the clinical course of primary lung carcinoma Pneumonologia Polska 48(3): 187-193
Andersen, K.S.; Johannessen, H. 1974: Gas transfer factor. Clinical and physiological aspects in changes of the lung diffusion capacity Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 94(25): 1527-1530
Hersh, E.M.; Mavligit, G.M.; Gutterman, J.U. 1974: Immunotherapy as related to lung cancer: a review Seminars in Oncology 1(3): 273-278
Rizvi, N.A. 2017: The use of immunotherapy in the first-line treatment of lung cancer Clinical Advances in Hematology and Oncology: H&o 15(3): 190-192
Meganem, H.; Socianu, R.-M.; Bouchaab, H.; Mederos, N.; Nguyen-Ngoc, T.; Peters, S.; Dolcan, A. 2019: The new management options for lung cancer in the immunotherapy era Revue Medicale Suisse 15(651): 1032-1037
Panettiere, F.J.; Constanzi, J.J. 1979: Advances in the chemotherapy and immunotherapy of lung cancer Texas Medicine 75(2): 95-97
Watanabe, Y.; Shimizu, J.; Oda, M.; Yoshida, M.; Watanabe, S.; Iwa, T. 1991: Clinical significance of immunotherapy for lung cancer--present and future Nihon Geka Gakkai Zasshi 92(9): 1217-1220
Muto, S.; Suzuki, H. 2018: Recent Advances in Immunotherapy for Non-Small Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(2): 212-216
Lenzi, M. 1977: Growth curves in radio-chemo-immunotherapy of lung cancer La Radiologia Medica 63(2): 111-120
Li, P.S. 1993: The future application of adoptive immunotherapy in treatment of lung cancer Zhonghua Nei Ke Za Zhi 32(9): 579-580
Schmähl, D. 1977: Chemo- and immunotherapy in cancer surgery Münchener Medizinische Wochenschrift 119(18): 601-602
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113